User talk:Beno Marija/proposal declined MitoEAGLE impact

From Bioblast
Jump to: navigation, search
Project Title Coordinator Status Start/End Funding agency
FunPharma Networking for excellence in functional pharmacology to study links between energy metabolism and cognition Latvian Institute of Organic Synthesis not funded n.a. H2020
AC4HEART Contribution of long-chain acylcarnitines to development of acute and chronic heart diseases Latvian Institute of Organic Synthesis not funded n.a. ERA-CCVD
FAT4BRAIN Networking for excellence in functional pharmacology to study the role of fatty acid metabolism in neurological disorders Latvian Institute of Organic Synthesis approved 2019-11 - 2022-11 H2020
Exercise and Physical Activity Research in Europe - from Knowledge to Action Pablo Miguel Garcia Roves Gonzalez submitted n.a. COST Action Proposal OC-2018-2-23310 to the COST Open Call OC-2018-2

Jordi Muntané Relat: have been submitted: Title: Functional impact of epigenetic regulation in hepatocarcinoma: Development of combined nanovectorization of miRNAs/lncRNAs and drugs useful in experimental liver cancer model Reference: PI19/01266

The project will identify the impact of antitumoral drugs recommended for the treatment of patients at intermediate stage (doxorubicin) and advanced (sorafenib, regorafenib, lenvatinib or cabozantinib) stages of hepatocarcinoma on their ability to regulate cell death and proliferation, translational profile, mRNA expression, mitochondrial function, migration and invasive capacity of HCC at different stages of cell differentiation. In particular, the workpackages related to the evaluation of mitochondrial function will address: 1) Impact of AMPK and Akt of PGC1α activation/inhibition and their repercussion on lipid/carbohydrate metabolism, mitochondrial biogenesis, mitochondrial respiration, conformation of mitochondrial complexes Working groups: TG3.2 Liver and TG4.2 Cultured cells. Members of the COST Action CA15203 MitoEAGLE involved: Zuzana Červinková. Other members will be included